Lisa Nessel

14.1k total citations · 6 hit papers
23 papers, 8.2k citations indexed

About

Lisa Nessel is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Lisa Nessel has authored 23 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Lisa Nessel's work include Gut microbiota and health (5 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Inflammatory Bowel Disease (4 papers). Lisa Nessel is often cited by papers focused on Gut microbiota and health (5 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Inflammatory Bowel Disease (4 papers). Lisa Nessel collaborates with scholars based in United States, United Kingdom and Canada. Lisa Nessel's co-authors include James D. Lewis, Gary D. Wu, Hongzhe Li, Frederic D. Bushman, Kyle Bittinger, Erin Gilroy, Christian Hoffmann, Robert N. Baldassano, Rohini Sinha and Rob Knight and has published in prestigious journals such as Science, JAMA and Gastroenterology.

In The Last Decade

Lisa Nessel

23 papers receiving 8.0k citations

Hit Papers

Linking Long-Term Dietary Patterns with Gut Microbial Ent... 2008 2026 2014 2020 2011 2008 2015 2011 2014 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Nessel United States 18 5.7k 2.3k 1.5k 1.3k 1.2k 23 8.2k
Matam Vijay–Kumar United States 51 6.0k 1.1× 2.4k 1.1× 1.7k 1.1× 1.5k 1.2× 1.4k 1.2× 152 11.6k
Meenakshi Bewtra United States 23 3.9k 0.7× 1.9k 0.8× 1.5k 1.0× 1.2k 1.0× 952 0.8× 60 6.4k
Rohini Sinha United States 13 5.5k 1.0× 2.0k 0.9× 885 0.6× 773 0.6× 1.5k 1.3× 15 7.7k
Jingyuan Fu Netherlands 52 8.3k 1.5× 2.7k 1.2× 2.2k 1.4× 1.6k 1.3× 1.6k 1.3× 142 12.9k
A. Sloan Devlin United States 17 7.1k 1.3× 3.1k 1.3× 922 0.6× 900 0.7× 1.6k 1.3× 25 9.8k
Erin Gilroy United States 9 4.6k 0.8× 2.1k 0.9× 1.0k 0.7× 711 0.6× 1.1k 0.9× 13 6.1k
Hervé M. Blottière France 45 6.6k 1.2× 2.3k 1.0× 1.5k 0.9× 1.0k 0.8× 1.7k 1.4× 129 10.3k
Marie Joossens Belgium 33 5.3k 0.9× 1.4k 0.6× 1.6k 1.1× 1.4k 1.1× 1.8k 1.5× 91 8.0k
John Penders Netherlands 51 5.9k 1.1× 2.3k 1.0× 1.0k 0.7× 1.5k 1.2× 1.7k 1.4× 169 11.8k
Monia Michaud United States 21 7.1k 1.3× 1.6k 0.7× 1.3k 0.8× 1.0k 0.8× 1.9k 1.6× 27 10.7k

Countries citing papers authored by Lisa Nessel

Since Specialization
Citations

This map shows the geographic impact of Lisa Nessel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Nessel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Nessel more than expected).

Fields of papers citing papers by Lisa Nessel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Nessel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Nessel. The network helps show where Lisa Nessel may publish in the future.

Co-authorship network of co-authors of Lisa Nessel

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Nessel. A scholar is included among the top collaborators of Lisa Nessel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Nessel. Lisa Nessel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujii, Naohiko, Takayuki Hamano, Jesse Y. Hsu, et al.. (2022). A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan. American Journal of Nephrology. 53(2-3). 226–239. 3 indexed citations
2.
Tanes, Ceylan, Kyle Bittinger, Yuan Gao, et al.. (2021). Role of dietary fiber in the recovery of the human gut microbiome and its metabolome. Cell Host & Microbe. 29(3). 394–407.e5. 201 indexed citations breakdown →
3.
Chassaing, Benoît, Victoria M. Gershuni, Liam McKeever, et al.. (2020). 1008 A RANDOMIZED CONTROLLED-FEEDING STUDY OF THE IMPACT OF THE SYNTHETIC DIETARY EMULSIFIER CARBOXYMETHYLCELLULOSE ON HUMAN HEALTH AND INTESTINAL MICROBIOTA. Gastroenterology. 158(6). S–200. 2 indexed citations
4.
Dienemann, Thomas, Naohiko Fujii, Paula Orlandi, et al.. (2016). International Network of Chronic Kidney Disease cohort studies (iNET-CKD): a global network of chronic kidney disease cohorts. BMC Nephrology. 17(1). 121–121. 36 indexed citations
5.
Lee, Dale, Robert N. Baldassano, Anthony Otley, et al.. (2015). Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohnʼs Disease. Inflammatory Bowel Diseases. 21(8). 1786–1793. 117 indexed citations
6.
Lewis, James D., Eric Z. Chen, Robert N. Baldassano, et al.. (2015). Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn’s Disease. Cell Host & Microbe. 18(4). 489–500. 612 indexed citations breakdown →
7.
Bernabé‐Ortiz, Antonio, Lisa Nessel, Robert H. Gilman, et al.. (2015). Burden of chronic kidney disease in Peru: a population-based study. The Lancet Global Health. 3. S34–S34. 2 indexed citations
8.
Osterman, Mark T., Faten Aberra, Raymond K. Cross, et al.. (2014). Mesalamine Dose Escalation Reduces Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 12(11). 1887–1893.e3. 65 indexed citations
9.
Wu, Gary D., Charlene Compher, Eric Z. Chen, et al.. (2014). Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production. Gut. 65(1). 63–72. 381 indexed citations breakdown →
10.
Lewis, James D., Laurel A. Habel, Charles P. Quesenberry, et al.. (2014). Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiology and Drug Safety. 23(6). 636–645. 23 indexed citations
11.
Townsend, Raymond R., Amanda H. Anderson, Jing Chen, et al.. (2011). Metabolic Syndrome, Components, and Cardiovascular Disease Prevalence in Chronic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Nephrology. 33(6). 477–484. 24 indexed citations
12.
Wu, Gary D., Jun Chen, Christian Hoffmann, et al.. (2011). Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes. Science. 334(6052). 105–108. 4705 indexed citations breakdown →
13.
Lewis, James D., Assiamira Ferrara, Tiffany Peng, et al.. (2011). Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone. Diabetes Care. 34(4). 916–922. 484 indexed citations breakdown →
14.
Wu, Gary D., James D. Lewis, Christian Hoffmann, et al.. (2010). Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags. BMC Microbiology. 10(1). 206–206. 314 indexed citations
15.
Lewis, James D., Brian L. Strom, A. Russell Localio, et al.. (2008). Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity. Pharmacoepidemiology and Drug Safety. 17(4). 328–335. 50 indexed citations
16.
Lewis, James D., Gary R. Lichtenstein, Julius J. Deren, et al.. (2008). Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial. Gastroenterology. 134(3). 688–695. 180 indexed citations
17.
Lewis, James D., Shaokun Chuai, Lisa Nessel, et al.. (2008). Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis. Inflammatory Bowel Diseases. 14(12). 1660–1666. 678 indexed citations breakdown →
18.
Makar, G.A., Mark G. Weiner, Stephen E. Kimmel, et al.. (2007). Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population. Pharmacoepidemiology and Drug Safety. 17(1). 43–51. 16 indexed citations
19.
Lewis, James D., Brian L. Strom, Stephen E. Kimmel, et al.. (2005). Predictors of recall of over‐the‐counter and prescription non‐steroidal anti‐inflammatory drug exposure. Pharmacoepidemiology and Drug Safety. 15(1). 39–45. 31 indexed citations
20.
Lewis, James D., Stephen E. Kimmel, A. Russell Localio, et al.. (2005). Risk of Serious Upper Gastrointestinal Toxicity With Over-the-Counter Nonaspirin Nonsteroidal Anti-inflammatory Drugs. Gastroenterology. 129(6). 1865–1874. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026